X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4291) 4291
proto-oncogene proteins b-raf - genetics (2826) 2826
mutation (2064) 2064
animals (1789) 1789
proto-oncogene proteins b-raf - metabolism (1723) 1723
female (1688) 1688
oncology (1606) 1606
male (1507) 1507
cancer (1445) 1445
cell line, tumor (1326) 1326
melanoma (1110) 1110
middle aged (1096) 1096
mice (1085) 1085
cell biology (975) 975
braf (952) 952
adult (905) 905
signal transduction (865) 865
aged (861) 861
proto-oncogene proteins b-raf - antagonists & inhibitors (829) 829
melanoma - genetics (799) 799
biochemistry & molecular biology (756) 756
phosphorylation (736) 736
tumors (735) 735
melanoma - pathology (693) 693
expression (671) 671
activation (662) 662
thyroid neoplasms - genetics (654) 654
melanoma - metabolism (642) 642
melanoma - drug therapy (615) 615
b-raf (598) 598
apoptosis (590) 590
protein kinase inhibitors - pharmacology (573) 573
genetic aspects (569) 569
kinases (559) 559
mutations (545) 545
research (536) 536
immunohistochemistry (509) 509
prognosis (493) 493
proteins (487) 487
antineoplastic agents - pharmacology (485) 485
thyroid neoplasms - pathology (479) 479
gene expression regulation, neoplastic (468) 468
neoplasms (461) 461
ras proteins - genetics (441) 441
gene mutations (439) 439
analysis (436) 436
pathology (434) 434
proto-oncogene proteins c-raf - metabolism (418) 418
endocrinology & metabolism (417) 417
pathway (413) 413
gene expression (411) 411
aged, 80 and over (403) 403
cell proliferation (400) 400
proto-oncogene proteins c-akt - metabolism (399) 399
signal transduction - drug effects (397) 397
extracellular signal-regulated map kinases - metabolism (390) 390
cell proliferation - drug effects (388) 388
metastasis (384) 384
mutation - genetics (379) 379
colorectal neoplasms - genetics (373) 373
proto-oncogene proteins - genetics (372) 372
dna mutational analysis (370) 370
carcinoma (366) 366
colorectal cancer (366) 366
braf mutation (361) 361
survival (355) 355
antineoplastic agents - therapeutic use (347) 347
multidisciplinary sciences (344) 344
vemurafenib (344) 344
apoptosis - drug effects (338) 338
gene (336) 336
map kinase (335) 335
ras proteins - metabolism (334) 334
care and treatment (332) 332
skin neoplasms - genetics (329) 329
research article (324) 324
cells (321) 321
mitogen-activated protein kinases - metabolism (319) 319
inhibition (316) 316
proto-oncogene proteins - metabolism (306) 306
sulfonamides - pharmacology (305) 305
protein kinase inhibitors - therapeutic use (304) 304
growth (303) 303
health aspects (301) 301
skin neoplasms - pathology (301) 301
young adult (300) 300
carcinoma, papillary - genetics (294) 294
thyroid neoplasms - metabolism (293) 293
indoles - pharmacology (292) 292
phosphatidylinositol 3-kinases - metabolism (291) 291
resistance (291) 291
metastatic melanoma (285) 285
digestive system diseases (282) 282
xenograft model antitumor assays (277) 277
proto-oncogene proteins p21 (276) 276
adolescent (273) 273
map kinase signaling system (270) 270
map kinase signaling system - drug effects (270) 270
dermatology (266) 266
medicine (262) 262
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4816) 4816
Chinese (31) 31
Japanese (12) 12
French (9) 9
Russian (8) 8
Hungarian (5) 5
German (4) 4
Portuguese (4) 4
Korean (2) 2
Spanish (2) 2
Bulgarian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature (London), ISSN 1476-4687, 2010, Volume 468, Issue 7326, pp. 973 - 977
Journal Article
Journal Article
Journal Article
Journal Article
Nature (London), ISSN 1476-4687, 2010, Volume 464, Issue 7287, pp. 427 - 430
Tumours with mutant BRAF are dependent on the RAF–MEK–ERK signalling pathway for their growth. We found that ATP-competitive RAF inhibitors inhibit ERK... 
SELECTIVE INHIBITOR | ACTIVATION | MELANOMA | MECHANISM | MULTIDISCIPLINARY SCIENCES | SENSITIVITY | HETERODIMERIZATION | KINASE INHIBITOR | B-RAF | CRAF | ONCOGENIC BRAF | Neoplasms - metabolism | ras Proteins - genetics | Phosphorylation | raf Kinases - antagonists & inhibitors | Humans | Protein Multimerization | Transcriptional Activation - drug effects | ras Proteins - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | raf Kinases - metabolism | Mitogen-Activated Protein Kinase Kinases - metabolism | Neoplasms - genetics | Adenosine Triphosphate - metabolism | Indoles - pharmacology | raf Kinases - genetics | Proto-Oncogene Proteins B-raf - metabolism | Proto-Oncogene Proteins B-raf - chemistry | Cell Line | raf Kinases - chemistry | Catalytic Domain | Neoplasms - enzymology | Enzyme Activation - drug effects | Sulfonamides - pharmacology | Neoplasms - drug therapy | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Animals | MAP Kinase Signaling System - drug effects | Models, Biological | Protein Kinase Inhibitors - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Cell Line, Tumor | Protein Binding | Mice | Protein Kinase Inhibitors - pharmacology | Protein Kinase Inhibitors - metabolism | Care and treatment | Enzyme inhibitors | Gene mutations | Cellular signal transduction | Genetic aspects | Research | Health aspects | Cancer | Proteins | Competition | Drugs | Mutation | Kinases | Tumors | Index Medicus
Journal Article
Cancer cell, ISSN 1535-6108, 2011, Volume 19, Issue 5, pp. 652 - 663
.... Ablation of B-Raf had no significant effect on tumor development. However, c-Raf expression was absolutely essential for the onset of NSCLC... 
C-RAF-1 GENE | APOPTOSIS | TUMOR PROGRESSION | ONCOLOGY | MAP KINASE | GROWTH | ORAL MEK INHIBITOR | PHASE-II | MICE | BRAF | CANCER | CELL BIOLOGY | Fibroblasts - enzymology | Cell Proliferation | Humans | Gene Expression Regulation, Neoplastic | Mitogen-Activated Protein Kinase 1 - deficiency | Lung Neoplasms - pathology | MAP Kinase Kinase 1 - genetics | Transfection | RNA Interference | Time Factors | Cellular Senescence | Mitogen-Activated Protein Kinase 1 - genetics | MAP Kinase Kinase 2 - genetics | Proto-Oncogene Proteins B-raf - metabolism | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Proto-Oncogene Proteins B-raf - deficiency | Lung Neoplasms - enzymology | MAP Kinase Kinase 2 - deficiency | Mitogen-Activated Protein Kinase 3 - genetics | Proto-Oncogene Proteins c-raf - genetics | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Tumor Burden | Proto-Oncogene Proteins c-raf - metabolism | Mice, Knockout | Gene Expression Regulation, Enzymologic | Animals | Proto-Oncogene Proteins B-raf - genetics | Proto-Oncogene Proteins c-raf - deficiency | Cell Line, Tumor | Mice | Mitogen-Activated Protein Kinase 3 - deficiency | Carcinoma, Non-Small-Cell Lung - enzymology | Genes, ras | Apoptosis | MAP Kinase Kinase 1 - deficiency | Development and progression | Carcinoma | Lung cancer, Non-small cell | Phosphotransferases | Cancer
Journal Article
Cell death and differentiation, ISSN 1350-9047, 08/2018, Volume 25, Issue 8, pp. 1442 - 1456
...; however, the underlying mechanisms are poorly understood. Here, we report that non-canonical Wnt signaling induced loss of chondrocyte phenotype through activation of Fz-6/DVL-2/SYND4/CaMKII alpha/B-raf/ERK1/2 cascade... 
PATHWAYS | ACTIVATION | POLARITY | WNT/BETA-CATENIN | MEMBRANE | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOLOGY | PROTEINS | EXPRESSION | KINASE-II | CARTILAGE | CELL BIOLOGY | Frizzled Receptors - antagonists & inhibitors | Chondrocytes - cytology | Phosphorylation | Dishevelled Proteins - antagonists & inhibitors | Humans | Syndecan-4 - genetics | Cell Dedifferentiation | Dishevelled Proteins - metabolism | Wnt Proteins - metabolism | MAP Kinase Signaling System | Syndecan-4 - antagonists & inhibitors | RNA Interference | Dishevelled Proteins - genetics | Osteoarthritis - pathology | Chondrocytes - metabolism | Proto-Oncogene Proteins B-raf - metabolism | Calcium-Calmodulin-Dependent Protein Kinase Type 2 - metabolism | Syndecan-4 - metabolism | Cells, Cultured | Frizzled Receptors - metabolism | Osteoarthritis - metabolism | beta Catenin - metabolism | beta Catenin - genetics | Phenotype | Frizzled Receptors - genetics | Proto-Oncogene Proteins B-raf - genetics | beta Catenin - antagonists & inhibitors | RNA, Small Interfering - metabolism | Heparan sulfate | Genotype & phenotype | Phenotypes | Wnt protein | Frizzled protein | Extracellular signal-regulated kinase | Raf protein | Chondrogenesis | Osteoarthritis | Syndecan | Dishevelled protein | Life Sciences | Subcellular Processes | Cellular Biology | Biochemistry, Molecular Biology
Journal Article
Journal Article
Journal Article
Nature (London), ISSN 1476-4687, 2011, Volume 480, Issue 7377, pp. 387 - 390
Journal Article
The Journal of biological chemistry, ISSN 1083-351X, 2011, Volume 286, Issue 15, pp. 13096 - 13105
.... A screen of protein kinases that bind to NHE1 revealed that B-Raf bound to the cytosolic regulatory tail of NHE1 Immunoprecipitation of NHE1 from He La and HEK cells confirmed the association of B-Raf with NHE1 in vivo... 
AMINO-ACIDS SER | PHOSPHORYLATION | PROTEIN-KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | COMPLEXES | GROWTH | FUNCTIONAL-ANALYSIS | BRAF | MELANOMA-CELLS | INHIBITORS | Niacinamide - analogs & derivatives | Humans | Phenylurea Compounds | Extracellular Signal-Regulated MAP Kinases - metabolism | Mutation, Missense | Extracellular Signal-Regulated MAP Kinases - genetics | Cell Movement - genetics | Sodium-Hydrogen Exchangers - metabolism | Benzenesulfonates - pharmacology | Phosphorylation - genetics | Protein Isoforms - metabolism | Cation Transport Proteins - metabolism | Melanoma - genetics | HEK293 Cells | Cation Transport Proteins - genetics | Indoles - pharmacology | Sodium-Hydrogen Exchangers - genetics | Phosphorylation - drug effects | Proto-Oncogene Proteins B-raf - metabolism | Melanoma - metabolism | Protein Structure, Tertiary | Rabbits | Cell Size | Melanoma - pathology | Sulfonamides - pharmacology | Cell Movement - drug effects | Animals | Proto-Oncogene Proteins B-raf - genetics | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | HeLa Cells | Sodium-Hydrogen Exchanger 1 | Amino Acid Substitution | Hydrogen-Ion Concentration | Protein Isoforms - genetics | Membrane Proteins | Membrane Enzymes | Membrane Biology | Sodium Proton Exchange | Melanoma | Cell pH | Membrane
Journal Article